6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03840837 (ClinicalTrials.gov)	May 2, 2019	11/2/2019	Cholinergic Neurotransmission in Mobility and Cognition in Parkinson Disease	Cholinergic Neurotransmission - A Common Underlying Mechanism of Cognitive and Gait Impairment in Pa ...	Parkinson Disease;Parkinson Disease Dementia	Drug: Rivastigmine transdermal patch	University of Maryland, Baltimore	National Institute on Aging (NIA)	Completed	18 Years	N/A	All	31	Phase 4	United States
2	NCT00623103 (ClinicalTrials.gov)	January 2008	14/2/2008	Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dement ...	A 76-week Prospective, Open-label, Multicenter Study to Evaluate the Long-term Effect of Rivastigmin ...	Parkinson's Disease Dementia	Drug: Rivastigmine capsule;Drug: Rivastigmine transdermal patch	Novartis	NULL	Completed	50 Years	85 Years	All	583	Phase 3	United States;Argentina;Australia;Austria;Belgium;Canada;France;Germany;Italy;Netherlands;Spain;Turk ...

First Previous1Next Last